Researchers find strains of the bacterium Klebsiella pneumoniae that produce high levels of alcohol in 60 percent of patients with the condition.

Separate proof-of-concept studies report success against two inherited diseases.

The Ireland-based pharma company makes a $1.7 billion offer to acquire Tobira Therapeutics, a US firm developing liver disease drugs.

Scientists have developed a way to selectively expand genetically modified hepatocytes in mice.

The timing of meals affects the levels of lipids in the livers of mice, according to a study.

Obesity drives an alteration of the gut microbiome, leading to the secretion of metabolites associated with the development of liver cancer.

Can we use science to reduce the harms of alcohol?